Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Morgan Creek-Exos Active SPAC Arbitrage ETF stock logo
CSH
Morgan Creek-Exos Active SPAC Arbitrage ETF
$25.63
+0.4%
$25.63
$22.22
$26.13
$8.20M-1.061,379 shs9,200 shs
Foran Mining Co. stock logo
FOM
Foran Mining
C$3.23
+3.9%
C$3.23
C$2.02
C$4.32
C$828.20M3.68494,615 shs1.03 million shs
GTT Communications, Inc. stock logo
GTT
GTT Communications
$2.08
$1.37
$8.38
$138.81M1.445.28 million shs106,327 shs
Li Auto Inc. stock logo
LI
Li Auto
$23.47
-1.7%
$33.23
$22.23
$47.33
$24.90B1.048.15 million shs6.80 million shs
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$125.80
-0.3%
$126.72
$75.56
$138.28
$564.53B0.414.82 million shs3.43 million shs
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Morgan Creek-Exos Active SPAC Arbitrage ETF stock logo
CSH
Morgan Creek-Exos Active SPAC Arbitrage ETF
0.00%0.00%0.00%0.00%0.00%
Foran Mining Co. stock logo
FOM
Foran Mining
0.00%0.00%0.00%0.00%-11.99%
GTT Communications, Inc. stock logo
GTT
GTT Communications
0.00%0.00%0.00%0.00%0.00%
Li Auto Inc. stock logo
LI
Li Auto
-3.79%-16.92%-21.74%-13.95%+8.35%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
-1.88%+1.32%-2.21%+19.42%+199.44%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Morgan Creek-Exos Active SPAC Arbitrage ETF stock logo
CSH
Morgan Creek-Exos Active SPAC Arbitrage ETF
N/AN/AN/AN/AN/AN/AN/AN/A
Foran Mining Co. stock logo
FOM
Foran Mining
0.9144 of 5 stars
3.50.00.00.00.61.70.0
GTT Communications, Inc. stock logo
GTT
GTT Communications
N/AN/AN/AN/AN/AN/AN/AN/A
Li Auto Inc. stock logo
LI
Li Auto
3.9498 of 5 stars
4.43.00.00.01.71.72.5
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
2.4813 of 5 stars
1.43.02.50.03.10.03.1

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Morgan Creek-Exos Active SPAC Arbitrage ETF stock logo
CSH
Morgan Creek-Exos Active SPAC Arbitrage ETF
0.00
N/AN/AN/A
Foran Mining Co. stock logo
FOM
Foran Mining
3.00
BuyC$5.1358.93% Upside
GTT Communications, Inc. stock logo
GTT
GTT Communications
N/AN/AN/AN/A
Li Auto Inc. stock logo
LI
Li Auto
3.00
Buy$45.3693.26% Upside
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
2.75
Moderate Buy$133.606.20% Upside

Current Analyst Ratings

Latest FOM, LI, CSH, NVO, and GTT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/25/2024
Li Auto Inc. stock logo
LI
Li Auto
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Equal Weight$39.00 ➝ $25.00
4/18/2024
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$160.00
4/15/2024
Li Auto Inc. stock logo
LI
Li Auto
Macquarie
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform ➝ Outperform$40.00
4/12/2024
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$163.00
4/1/2024
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$160.00
3/25/2024
Li Auto Inc. stock logo
LI
Li Auto
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$74.00 ➝ $65.00
3/22/2024
Li Auto Inc. stock logo
LI
Li Auto
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$57.30 ➝ $48.50
3/22/2024
Li Auto Inc. stock logo
LI
Li Auto
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$56.00 ➝ $39.00
3/20/2024
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$160.00
3/18/2024
Li Auto Inc. stock logo
LI
Li Auto
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$60.00 ➝ $55.00
3/4/2024
Li Auto Inc. stock logo
LI
Li Auto
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$57.00 ➝ $60.00
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Morgan Creek-Exos Active SPAC Arbitrage ETF stock logo
CSH
Morgan Creek-Exos Active SPAC Arbitrage ETF
N/AN/AN/AN/AN/AN/A
Foran Mining Co. stock logo
FOM
Foran Mining
N/AN/AC$0.15 per share21.23C$0.96 per shareN/A
GTT Communications, Inc. stock logo
GTT
GTT Communications
$1.73B0.00N/A0.60$5.14 per share0.00
Li Auto Inc. stock logo
LI
Li Auto
$17.44B1.43$1.45 per share16.23$8.04 per share2.92
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$33.71B16.75$2.94 per share42.72$3.45 per share36.46

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Morgan Creek-Exos Active SPAC Arbitrage ETF stock logo
CSH
Morgan Creek-Exos Active SPAC Arbitrage ETF
N/AN/A28.81N/AN/AN/AN/AN/A
Foran Mining Co. stock logo
FOM
Foran Mining
-C$12.87M-C$0.05N/AN/AN/A-6.01%-3.01%N/A
GTT Communications, Inc. stock logo
GTT
GTT Communications
-$105.90MN/A0.00N/AN/AN/AN/AN/AN/A
Li Auto Inc. stock logo
LI
Li Auto
$1.65B$1.5515.147.70N/A9.44%18.37%8.39%5/8/2024 (Estimated)
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$12.15B$2.7146.5130.762.1536.03%90.36%29.18%5/2/2024 (Confirmed)

Latest FOM, LI, CSH, NVO, and GTT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/2/2024N/A
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$0.77N/A-$0.77N/AN/AN/A  
2/26/2024Q4 2023
Li Auto Inc. stock logo
LI
Li Auto
N/A$0.49+$0.49$0.23N/A$5.88 billion
1/31/2024Q4 2023
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$0.66$0.71+$0.05$0.71$9.14 billion$9.51 billion

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Morgan Creek-Exos Active SPAC Arbitrage ETF stock logo
CSH
Morgan Creek-Exos Active SPAC Arbitrage ETF
N/AN/AN/AN/AN/A
Foran Mining Co. stock logo
FOM
Foran Mining
N/AN/AN/AN/AN/A
GTT Communications, Inc. stock logo
GTT
GTT Communications
N/AN/AN/AN/AN/A
Li Auto Inc. stock logo
LI
Li Auto
N/AN/AN/AN/AN/A
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$1.331.06%+16.52%49.17%1 Years

Latest FOM, LI, CSH, NVO, and GTT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
1/31/2024
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
Semi-Annual$0.66400.9%3/22/20243/25/20244/2/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Morgan Creek-Exos Active SPAC Arbitrage ETF stock logo
CSH
Morgan Creek-Exos Active SPAC Arbitrage ETF
N/AN/AN/A
Foran Mining Co. stock logo
FOM
Foran Mining
13.01
6.55
2.90
GTT Communications, Inc. stock logo
GTT
GTT Communications
N/AN/AN/A
Li Auto Inc. stock logo
LI
Li Auto
0.03
1.57
1.48
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
0.19
0.82
0.64

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Morgan Creek-Exos Active SPAC Arbitrage ETF stock logo
CSH
Morgan Creek-Exos Active SPAC Arbitrage ETF
N/A320,000N/ANot Optionable
Foran Mining Co. stock logo
FOM
Foran Mining
N/A256.41 millionN/ANot Optionable
GTT Communications, Inc. stock logo
GTT
GTT Communications
3,10058.82 millionN/AOptionable
Li Auto Inc. stock logo
LI
Li Auto
31,5911.06 billion546.42 millionOptionable
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
63,3704.49 billion4.48 billionOptionable

FOM, LI, CSH, NVO, and GTT Headlines

SourceHeadline
Novo Nordisk lands back in Sanders crosshairs, this time over steep cost of Ozempic and WegovyNovo Nordisk lands back in Sanders' crosshairs, this time over steep cost of Ozempic and Wegovy
fiercepharma.com - April 25 at 5:23 PM
Sanders takes aim at US drug prices of Novo’s Ozempic and WegovySanders takes aim at US drug prices of Novo’s Ozempic and Wegovy
pharmaceutical-technology.com - April 25 at 5:23 PM
Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck and AbbVieZacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck and AbbVie
finance.yahoo.com - April 25 at 12:22 PM
Novo Nordisk A/S (NVO) to Release Earnings on ThursdayNovo Nordisk A/S (NVO) to Release Earnings on Thursday
americanbankingnews.com - April 25 at 4:46 AM
Wynn Capital LLC Invests $749,000 in Novo Nordisk A/S (NYSE:NVO)Wynn Capital LLC Invests $749,000 in Novo Nordisk A/S (NYSE:NVO)
marketbeat.com - April 24 at 6:56 PM
Novo Nordisk (NVO) Stock Sinks As Market Gains: Heres WhyNovo Nordisk (NVO) Stock Sinks As Market Gains: Here's Why
zacks.com - April 24 at 6:51 PM
Novo Nordisk A/S (NYSE:NVO) Trading Down 2.1%Novo Nordisk A/S (NYSE:NVO) Trading Down 2.1%
marketbeat.com - April 24 at 4:22 PM
Senate launches investigation into high prices of Ozempic and Wegovy in the U.S.Senate launches investigation into high prices of Ozempic and Wegovy in the U.S.
cnbc.com - April 24 at 3:22 PM
US Senate committee investigates pricing of Novos Ozempic and WegovyUS Senate committee investigates pricing of Novo's Ozempic and Wegovy
reuters.com - April 24 at 2:37 PM
3 Biotech Stocks With Skyrocketing Potential: April 20243 Biotech Stocks With Skyrocketing Potential: April 2024
investorplace.com - April 24 at 11:36 AM
4 Large Drug Stocks to Hold on to Amid Industry Challenges4 Large Drug Stocks to Hold on to Amid Industry Challenges
zacks.com - April 24 at 11:11 AM
Novo Nordisk A/S - Articles of Association, April 2024Novo Nordisk A/S - Articles of Association, April 2024
globenewswire.com - April 24 at 8:57 AM
Novo Nordisk A/S – Reduction of the share capitalNovo Nordisk A/S – Reduction of the share capital
globenewswire.com - April 24 at 8:48 AM
Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon.Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon.
fool.com - April 24 at 5:50 AM
Schnieders Capital Management LLC Boosts Position in Novo Nordisk A/S (NYSE:NVO)Schnieders Capital Management LLC Boosts Position in Novo Nordisk A/S (NYSE:NVO)
marketbeat.com - April 23 at 11:25 PM
Novo Nordisk A/S (NYSE:NVO) Stock Price Up 2.1%Novo Nordisk A/S (NYSE:NVO) Stock Price Up 2.1%
marketbeat.com - April 23 at 2:58 PM
Novo Nordisk (NVO) Boasts Earnings & Price Momentum: Should You Buy?Novo Nordisk (NVO) Boasts Earnings & Price Momentum: Should You Buy?
zacks.com - April 23 at 10:31 AM
Why Novo Nordisk Topped the Market TodayWhy Novo Nordisk Topped the Market Today
fool.com - April 22 at 6:08 PM
RWA Wealth Partners LLC Acquires 72,924 Shares of Novo Nordisk A/S (NYSE:NVO)RWA Wealth Partners LLC Acquires 72,924 Shares of Novo Nordisk A/S (NYSE:NVO)
marketbeat.com - April 22 at 3:46 PM
Novo Nordisk A/S (NYSE:NVO) Stock Price Up 1.7%Novo Nordisk A/S (NYSE:NVO) Stock Price Up 1.7%
marketbeat.com - April 22 at 2:32 PM
Changing Frugal Eating Habits - How Novo Nordisk/Eli Lillys Weight Loss Drugs Reshaping Food SpendingChanging Frugal Eating Habits - How Novo Nordisk/Eli Lilly's Weight Loss Drugs Reshaping Food Spending
msn.com - April 22 at 2:31 PM
Novo Nordisk A/S - share repurchase programmeNovo Nordisk A/S - share repurchase programme
globenewswire.com - April 22 at 9:06 AM
Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
marketbeat.com - April 22 at 6:05 AM
Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
marketbeat.com - April 22 at 6:05 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Morgan Creek-Exos Active SPAC Arbitrage ETF logo

Morgan Creek-Exos Active SPAC Arbitrage ETF

NYSEARCA:CSH
The Morgan Creek-Exos Active SPAC Arbitrage ETF (CSH) is an exchange-traded fund that mostly invests in extended market equity. The fund is actively managed to provide exposure to US-listed pre-combination special purpose acquisition companies (SPACs) through the use of common stock, warrants and rights. Positions will generally be in small- and mid-cap companies. CSH was launched on Feb 1, 2022 and is managed by Morgan Creek.
Foran Mining logo

Foran Mining

CVE:FOM
Foran Mining Corporation engages in the acquisition, exploration, and development of mineral properties. The company primarily explores for copper, zinc, gold, and silver deposits. Its flagship project is the McIlvenna Bay property comprising 38 claims that covers a total area of 20,907 hectares located in east central Saskatchewan. The company was incorporated in 1989 and is headquartered in Vancouver, Canada.
GTT Communications logo

GTT Communications

NYSE:GTT
GTT Communications, Inc. provides cloud networking services to multinational enterprises, carriers, and government customers in the United States, Europe, and internationally. The company offers wide area networking, such as software-defined wide area networking, multiprotocol label switching, and virtual private LAN service; high bandwidth-Internet connectivity and IP transit, as well as broadband and wireless Internet access services; managed equipment and security services; and unified communication services consisting of session initiation protocol trunking, cloud unified communication service, and traditional analog voice. It also provides transport services, such as Ethernet services that enable to design network equipment; and video transport services to support broadcast quality transmission of live events, sports entertainment, and news to media and entertainment industry. In addition, the company offers infrastructure services enabling transport of high volume data between data centers, enterprise office locations, and media hubs; wavelength services to deliver scalable high-performance optical connectivity; colocation, turnkey, duct, and dark fiber services; advanced solutions, including security, hybrid cloud, database, and application management Its IP network consists of approximately 600 points of presence. GTT Communications, Inc. markets its products and services through a network of direct sales force and indirect sales channels. The company was formerly known as Global Telecom & Technology, Inc. and changed its name to GTT Communications, Inc. in January 2014. GTT Communications, Inc. was founded in 2005 and is headquartered in McLean, Virginia.
Li Auto logo

Li Auto

NASDAQ:LI
Li Auto Inc. operates in the energy vehicle market in the People's Republic of China. It designs, develops, manufactures, and sells premium smart electric vehicles. The company's product line comprises MPVs and sport utility vehicles. It offers sales and after sales management, and technology development and corporate management services, as well as purchases manufacturing equipment. The company offers its products through online and offline channels. The company was formerly known as Leading Ideal Inc. and changed its name to Li Auto Inc. in July 2020. Li Auto Inc. was founded in 2015 and is headquartered in Beijing, the People's Republic of China.
Novo Nordisk A/S logo

Novo Nordisk A/S

NYSE:NVO
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.